South Korea · Delayed Price · Currency is KRW SD Biosensor Statistics
Total Valuation
SD Biosensor has a market cap or net worth of KRW 980.88 billion. The enterprise value is 886.93 billion.
| Market Cap | 980.88B |
| Enterprise Value | 886.93B |
Important Dates
The last earnings date was Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
SD Biosensor has 119.62 million shares outstanding. The number of shares has decreased by -2.10% in one year.
| Current Share Class | 119.62M |
| Shares Outstanding | 119.62M |
| Shares Change (YoY) | -2.10% |
| Shares Change (QoQ) | -0.32% |
| Owned by Insiders (%) | 32.63% |
| Owned by Institutions (%) | 2.61% |
| Float | 31.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.38 |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | 3.26 |
| P/OCF Ratio | 2.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.62, with an EV/FCF ratio of 2.95.
| EV / Earnings | -1.73 |
| EV / Sales | 1.25 |
| EV / EBITDA | 22.62 |
| EV / EBIT | n/a |
| EV / FCF | 2.95 |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.64 |
| Quick Ratio | 2.01 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | 13.09 |
| Debt / FCF | 2.24 |
| Interest Coverage | -0.77 |
Financial Efficiency
Return on equity (ROE) is -19.49% and return on invested capital (ROIC) is -3.21%.
| Return on Equity (ROE) | -19.49% |
| Return on Assets (ROA) | -1.45% |
| Return on Invested Capital (ROIC) | -3.21% |
| Return on Capital Employed (ROCE) | -2.98% |
| Weighted Average Cost of Capital (WACC) | 10.08% |
| Revenue Per Employee | 1.23B |
| Profits Per Employee | -889.07M |
| Employee Count | 576 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | -404.75B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.50% in the last 52 weeks. The beta is 0.73, so SD Biosensor's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -2.50% |
| 50-Day Moving Average | 8,263.20 |
| 200-Day Moving Average | 9,392.55 |
| Relative Strength Index (RSI) | 55.37 |
| Average Volume (20 Days) | 102,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SD Biosensor had revenue of KRW 710.58 billion and -512.11 billion in losses. Loss per share was -4,279.00.
| Revenue | 710.58B |
| Gross Profit | 321.45B |
| Operating Income | -82.85B |
| Pretax Income | -918.14B |
| Net Income | -512.11B |
| EBITDA | 51.41B |
| EBIT | -82.85B |
| Loss Per Share | -4,279.00 |
Balance Sheet
The company has 774.17 billion in cash and 673.04 billion in debt, with a net cash position of 101.13 billion or 845.47 per share.
| Cash & Cash Equivalents | 774.17B |
| Total Debt | 673.04B |
| Net Cash | 101.13B |
| Net Cash Per Share | 845.47 |
| Equity (Book Value) | 2.34T |
| Book Value Per Share | 19,479.62 |
| Working Capital | 766.56B |
Cash Flow
In the last 12 months, operating cash flow was 357.52 billion and capital expenditures -57.09 billion, giving a free cash flow of 300.43 billion.
| Operating Cash Flow | 357.52B |
| Capital Expenditures | -57.09B |
| Depreciation & Amortization | 134.27B |
| Net Borrowing | 8.01B |
| Free Cash Flow | 300.43B |
| FCF Per Share | 2,511.56 |
Margins
Gross margin is 45.24%, with operating and profit margins of -11.66% and -72.07%.
| Gross Margin | 45.24% |
| Operating Margin | -11.66% |
| Pretax Margin | -129.21% |
| Profit Margin | -72.07% |
| EBITDA Margin | 7.24% |
| EBIT Margin | -11.66% |
| FCF Margin | 42.28% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.44%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 2.44% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.10% |
| Shareholder Yield | 4.54% |
| Earnings Yield | -52.21% |
| FCF Yield | 30.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SD Biosensor has an Altman Z-Score of 1.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 4 |